Saturday - April 25, 2026
CHPA Underscores Value of OTC Medicines at FDA Public Meeting
April 25, 2026
WASHINGTON, April 25 (TNSrpt) -- The Consumer Healthcare Products Association issued the following statement on April 23, 2026:

* * *

CHPA Underscores Value of OTC Medicines at FDA Public Meeting

The Consumer Healthcare Products Association (CHPA) issued the below statement today following remarks by CHPA Senior Vice President of Legal, Policy & Government Affairs David Spangler during a panel convened by the Duke-Margolis Institute for Health Policy, & . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products